Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.

Item

http://www.wikidata.org/entity/Q27324818

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Points to consider for priorit ...... ountability for reasonableness

@nl

Points to consider for priorit ...... untability for reasonableness.

@ast

Points to consider for priorit ...... untability for reasonableness.

@en

type

Item

label

Points to consider for priorit ...... ountability for reasonableness

@nl

Points to consider for priorit ...... untability for reasonableness.

@ast

Points to consider for priorit ...... untability for reasonableness.

@en

prefLabel

Points to consider for priorit ...... ountability for reasonableness

@nl

Points to consider for priorit ...... untability for reasonableness.

@ast

Points to consider for priorit ...... untability for reasonableness.

@en

P1476

Points to consider for priorit ...... untability for reasonableness.

@en

P2093

Alastair Kent

http://www.w3.org/2001/XMLSchema#string

Arne Pfeufer

http://www.w3.org/2001/XMLSchema#string

Celine Lewis

http://www.w3.org/2001/XMLSchema#string

EuroGentest and ESHG/PPPC Priority Consortium

http://www.w3.org/2001/XMLSchema#string

Florence Fellmann

http://www.w3.org/2001/XMLSchema#string

Florian Koerber

http://www.w3.org/2001/XMLSchema#string

Franziska Severin

http://www.w3.org/2001/XMLSchema#string

Georg Marckmann

http://www.w3.org/2001/XMLSchema#string

Heidi C Howard

http://www.w3.org/2001/XMLSchema#string

Jürgen John

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

The $1,000 genome, the $100,000 analysis?

Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine

DNA-based genetic testing is rising steeply in a national health care system with open access to services: a survey of genetic test use in Germany, 1996-2002.

Technology assessment and resource allocation for predictive genetic testing: a study of the perspectives of Canadian genetic health care providers

Eliciting preferences for priority setting in genetic testing: a pilot study comparing best-worst scaling and discrete-choice experiments.

Points to consider in assessing and appraising predictive genetic tests.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Economic analyses of human genetics services: a systematic review.

P2888

ejhg.2014.190

P304

729-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EJHG.2014.190

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1041813134

http://www.w3.org/2001/XMLSchema#string

P698

25248395

http://www.w3.org/2001/XMLSchema#string

P932

4795066

http://www.w3.org/2001/XMLSchema#string